DB09201ExperimentalSmall molecule
Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in... Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market.
- Mechanism
- Curator reviewed
Pharmacologically active on Peroxisome proliferator-activated receptor gamma
- Formula / weight
- C18H23NO3S · 333.45 g/mol (avg)
Resolves to
Structure
InChIKey
YZFWTZACSRHJQD-UHFFFAOYSA-NSMILESCC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1Targets
What you can answer from here — as of May 05, 2022
Which drugs share a target with Ciglitazone, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account